EarliPoint Health receives expanded FDA clearance for autism assessment in children up to age 8.

Read Release →

How ABA Practice Operations Are Evolving in 2026

On This Page

The operational picture for ABA practices has shifted meaningfully over the last 18 to 24 months. Some of the change is driven by external forces (payer dynamics, workforce supply, M&A consolidation, technology availability). Some is driven internally by practices working out how to operate sustainably at a scale that few were operating at five years ago. Either way, today’s practice operations differ from those of relatively recent times, and the practices that adapt most effectively share a set of operational patterns.

This piece looks at those patterns. The audience is ABA practice owners and clinical directors trying to understand what operational shifts are worth investing in. The framing is observational, drawn from what practices that appear to be adapting effectively tend to be doing.

Pattern 1: Treating Diagnosis as Part of the Practice’s Core Capability

The historical model for many ABA practices was to start working with children after a diagnosis had been established elsewhere. Increasingly, that model is being supplemented or replaced by one in which the practice handles a substantial share of the evaluation work itself.

This isn’t a clinical claim about which model is better. It’s an operational observation: practices that integrate diagnostic services tend to control a larger share of their patient pipeline, achieve shorter time-to-therapy, and produce different payer documentation than practices that depend entirely on outside evaluation. The technology that makes this practical in an ABA context (notably, FDA-cleared tools that allow technician-administered, clinician-interpreted assessment) has matured to the point where it’s a credible operational option for many practices that wouldn’t have considered it a few years ago.

The EarliPoint System is one example of this category of tool. It’s FDA-cleared to aid qualified clinicians in diagnosing and assessing ASD in children 16 to 95 months old who are at risk based on concerns from a parent, caregiver, or healthcare provider. The model of behavior technician administration with clinician interpretation is what makes the in-house diagnostic operation viable in practices that don’t have multiple developmental-behavioral pediatricians on staff.

Pattern 2: Treating Intake as a Clinical Process

A related pattern is the elevation of intake from a scheduling function to a clinical interaction. The historical model treated intake as logistics: verify insurance, get demographics, schedule the first appointment. The emerging pattern treats intake as the first clinical interaction with the family.

In practice, this involves capturing a structured developmental history, conducting parent interview elements before the in-person visit, completing screening tools (M-CHAT-R/F for younger children; age-appropriate alternatives for older children) during the intake process, and resolving insurance and authorization questions before the family arrives.

The operational gain is significant. Time per evaluation decreases, family experience improves, and the data captured at intake support both the clinical workflow and downstream documentation requirements.

Pattern 3: Building Referral Relationships With Operational Discipline

Pediatric referral relationships remain a primary source of new patients for most ABA practices. The practices that have grown most effectively over the last several years tend to treat those relationships with the same operational discipline that well-run B2B sales teams treat key accounts.

This means named relationship owners on the ABA practice side, defined communication cadences with referring practices, closed-loop reporting on every referral (acknowledgment, scheduling confirmation, evaluation completion, report delivery), and ongoing outreach that doesn’t stop after the first referral.

The practices that don’t do this typically lack clinical capability. They’re missing the operational consistency that turns a single referral into a reliable pattern.

Pattern 4: Investing in Family Experience as an Operational Design Choice

Family experience used to be discussed largely as a soft factor. Increasingly, it’s being treated as an operational design choice with measurable consequences. Families who have a good experience during evaluation are more likely to engage with the recommended intervention pathway. Families who don’t are more likely to disengage.

The practices designed for this consistently invest in the same handful of things: clear pre-visit communication, structured intake that doesn’t feel rushed, a comfortable evaluation environment for young children, a structured feedback session after the evaluation, and proactive communication during the period between evaluation and the start of services.

None of this is exotic. What separates the practices that do it from those that don’t is that it’s an explicit operational priority rather than a default.

Pattern 5: Communicating Wait Time Honestly

A specific marketing and operational pattern emerging across practices that have improved their evaluation throughput: publishing wait time information publicly. Where regional norms for autism evaluation sit at multiple months, practices that can credibly offer a shorter window have started surfacing that information directly in their websites, referring physician communications, and family-facing materials.

The framing matters. This isn’t marketing language. It’s straightforward operational information that families and referring providers find useful. The practices that consistently communicate it tend to convert a higher percentage of inquiries into scheduled evaluations.

Pattern 6: Planning for Payer Evolution

Payer dynamics in the autism services space have continued to shift. Commercial carriers and Medicaid programs have increasingly pushed for more objective documentation at every stage of care: better-structured diagnoses, more measurable progress monitoring, cleaner re-authorization criteria. The practices that have adapted most successfully are those that build their workflows to anticipate this rather than respond to it after the fact.

The practical implications include structured assessments that produce consistent documentation, technology-supported workflows that generate reliable data, and operational designs that enable the practice to produce the documentation that payers increasingly request without significant manual rework.

Closing Thought

The common thread across these patterns isn’t any single innovation. It’s a shift toward operational consistency as the primary differentiator. Clinical excellence is increasingly necessary but no longer sufficient. The practices that operate most effectively are those that have built the systems, relationships, and infrastructure to deliver clinical work consistently across patient, payer, and referral interactions.

For practices evaluating where to invest operational attention over the next 12 to 18 months, these patterns are a useful frame. Each is implementable. None is unusually complex. What separates the practices that adopt them from those that don’t is sustained operational focus rather than capability.

For practices considering how the EarliPoint System might support operational consistency in their evaluation workflow, our provider network team is a starting point.

Pete Polgar

VP of Marketing

Pete Polgar is the Vice President of Marketing at Earlipoint. He leads the company’s marketing strategy, focusing on brand positioning, demand generation, and digital growth. With a background in performance marketing and content strategy, Pete works on aligning marketing initiatives with business development to drive measurable results and expand Earlipoint’s market presence.

Pete Polgar

VP of Marketing

Pete leads EarliPoint’s marketing strategy — driving brand growth, demand generation, and measurable business results.

See how EarliPoint fits seamlessly into your clinical workflow.

Jamie Pagliaro brings over two decades of leadership in autism and behavioral health to his role as President and CEO of EarliPoint. Most recently, he served as Chief Operating Officer at Rethink, a leading SaaS provider supporting individuals with autism and developmental disabilities. Under his leadership, Rethink’s behavioral health division became the company’s largest business unit, serving thousands of clinicians and driving scalable, tech-enabled care delivery.

Earlier in his career, Jamie was Executive Director of the New York Center for Autism Charter School, the first public charter school in New York State dedicated to children with autism. At EarliPoint, he leads the company’s mission to bring breakthrough science to the front lines of care—empowering providers, families, and health systems with earlier answers and better outcomes.

Jamie Pagliaro

President & Chief Executive Officer

Dr. Ami Klin is a globally recognized leader in autism research and early detection. As Director of the Marcus Autism Center and Division Chief of Autism and Developmental Disabilities at Emory University School of Medicine, he has dedicated his career to understanding how young children engage with the social world—and how subtle disruptions in attention can signal developmental differences. His pioneering work in eye-tracking science led to the development of EarliPoint™ Evaluation, the first FDA-authorized tool to objectively assess autism in children as young as 16 months.
At EarliPoint, Dr. Klin drives clinical strategy and innovation, ensuring that families and clinicians worldwide have access to timely, science-based insights that enable earlier, more personalized intervention. His career reflects a deep commitment to transforming how society supports children with autism—starting with the earliest signs.

Ami Klin, PhD

Chief Clinical Officer & Co‑Founder